Cystinuria is well-suited for gene therapy, mainly because of the disease’s autosomal recessive nature and manageable gene sizes (SLC3A1 2.3 kb, SLC7A9 1.8 kb), also, the core of the pathogenic mechanisms is located in the proximal tubule, which is easily accessible. The gene discussed is SLC7A9; the disease is cystinuria.